Microbix Biosystems Inc. (TSE:MBX – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.24 and traded as low as C$0.24. Microbix Biosystems shares last traded at C$0.24, with a volume of 12,873 shares.
Microbix Biosystems Stock Performance
The stock’s 50-day simple moving average is C$0.24 and its 200-day simple moving average is C$0.26. The stock has a market cap of C$32.62 million, a price-to-earnings ratio of -14.69 and a beta of 0.20. The company has a current ratio of 7.15, a quick ratio of 5.57 and a debt-to-equity ratio of 22.61.
Microbix Biosystems (TSE:MBX – Get Free Report) last released its quarterly earnings results on Thursday, December 18th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$3.74 million during the quarter. Microbix Biosystems had a net margin of 13.86% and a return on equity of 12.65%. Analysts forecast that Microbix Biosystems Inc. will post 0.02 earnings per share for the current fiscal year.
About Microbix Biosystems
Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.
Recommended Stories
- Five stocks we like better than Microbix Biosystems
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
